Clinical trial

Radium 223 in Castrate Resistant Prostate Cancer Bone Metastases

NCT02135484

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-09-19

PhaseNA

Study timeline

Study start (actual)2014-09-19Date precision: day

Registry last updated2022-02-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

AlpharadinDRUG

Sponsors & collaborators

M.D. Anderson Cancer Centerlead sponsor

Bayercollaborator

Prostate Cancer Foundationcollaborator

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02135484 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.